TECHNOLOGY PLATFORMS APIs DRUG PRODUCTS INTEGRATED SUPPLY FACILITIES ABOUT US CONTACT US NEWS & PRESS EVENTS RESOURCE LIBRARY CAREERS CORDENPHARMA BOULDER (CO, US) Home >> Facilities >> CordenPharma Boulder (CO,... HIGHLY POTENT API VIDEO CORDENPHARMA 15 YEAR ANNIVERSARY CORE CAPABILITIES >> Development & manufacturing of highly potent, cytotoxic & cytostatic APIs >> Development to commercial quantities >> Highly potent chromatography expertise CAPACITIES READ FACT SHEET COMPLIANCE >> Long history of successful US FDA inspections >> PMDA inspected with zero critical observations >> Inspected by TGA >> Inspected by MHRA RELATED PRODUCTS & PLATFORMS APIs >> Highly Potent & Oncology >> API Support Services Drug Products >> Oral Formulation Tablets & Capsules >> Sterile Liquids Technology Platforms Small Molecules Highly Potent & Oncology FACILITY LEGACY CordenPharma Boulder is a world leader in the development and manufacturing of highly potent cytotoxic and cytostatic products, bringing expertise in process development, scale-up and cGMP manufacturing for highly potent APIs as well as experience in handling compounds below 10ng/m3 OEL. HISTORY >> 1991: Site founded as NaPro Biotherapeutics >> 2003: Mayne Pharma acquired the facility >> 2007: Became a member of Hospira due to the acquisition of Mayne >> 2015: Pfizer acquired Hospira >> 2017: Acquired by ICIG to become Corden Pharma Boulder Keyboard shortcuts Map data ©2021 Terms of Use Report a map error View in Google Maps Managing Director Brian McCudden Corden Pharma Boulder 4876 Sterling Drive Boulder 80301 Phone: +1 303 442-1926 Ext. 6623 Fax: +1 303 938-1255 Email Human Resources OPEN JOBS NEWS & PRESS EVENTS RESOURCE LIBRARY CAREERS ABOUT US CONTACT US TERMS AND CONDITIONS PRIVACY POLICY MEDIA CONTACT IMPRESSUM SITE MAP COVID-19 UPDATE Also of Interest: Peptides Company Sterile Injectables New GMP Peptide Expansion in Colorado ©2021 CordenPharma International Website created by Advanta Advertising, LLC